NASDAQ:CUTR - Cutera Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $18.40 +0.55 (+3.08 %) (As of 03/21/2019 02:30 AM ET)Previous Close$17.85Today's Range$17.65 - $18.8352-Week Range$12.32 - $56.05Volume162,621 shsAverage Volume257,057 shsMarket Capitalization$255.83 millionP/E Ratio-8.25Dividend YieldN/ABeta0.73 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cutera, Inc., a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating. It also provides excel V, a vascular and benign pigmented lesion treatment platform; xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, fine lines, and laxity; Juliet, a laser system for vaginal health; and Secret RF, a fractional radio frequency microneedling device for skin rejuvenation. In addition, the company offers GenesisPlus system, a laser product for use in the temporary increase of clear nails in patients with onychomycosis, as well as for the treatment of fine wrinkles, diffuse redness, and rosacea; and CoolGlide, as well as myQ, a third-party sourced system for the Japanese market. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills and marketing brochures through the Internet. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, physicians performing aesthetic treatments in non-medical offices, and other qualified practitioners, as well as for physicians offering aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1998 and is headquartered in Brisbane, California. Receive CUTR News and Ratings via Email Sign-up to receive the latest news and ratings for CUTR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorComputer and Technology Current SymbolNASDAQ:CUTR Previous Symbol CUSIPN/A CIK1162461 Webwww.cutera.com Phone415-657-5500Debt Debt-to-Equity RatioN/A Current Ratio1.83 Quick Ratio1.24Price-To-Earnings Trailing P/E Ratio-8.25 Forward P/E Ratio-55.76 P/E GrowthN/A Sales & Book Value Annual Sales$162.72 million Price / Sales1.57 Cash FlowN/A Price / Cash FlowN/A Book Value$3.34 per share Price / Book5.51Profitability EPS (Most Recent Fiscal Year)($2.23) Net Income$-30,770,000.00 Net Margins-18.91% Return on Equity-48.46% Return on Assets-27.95%Miscellaneous EmployeesN/A Outstanding Shares13,904,000Market Cap$255.83 million Next Earnings Date5/14/2019 (Estimated) OptionableOptionable Cutera (NASDAQ:CUTR) Frequently Asked Questions What is Cutera's stock symbol? Cutera trades on the NASDAQ under the ticker symbol "CUTR." How will Cutera's stock buyback program work? Cutera announced that its board has initiated a stock repurchase program on Tuesday, August 8th 2017, which authorizes the company to buyback $25,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to buy up to 6.8% of its stock through open market purchases. Stock buyback programs are typically a sign that the company's board believes its stock is undervalued. How were Cutera's earnings last quarter? Cutera, Inc. (NASDAQ:CUTR) issued its quarterly earnings results on Wednesday, February, 20th. The medical device company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by $0.14. The medical device company had revenue of $45.47 million for the quarter, compared to analysts' expectations of $44.29 million. Cutera had a negative return on equity of 48.46% and a negative net margin of 18.91%. The business's quarterly revenue was down 4.5% on a year-over-year basis. During the same period last year, the business earned $0.42 earnings per share. View Cutera's Earnings History. When is Cutera's next earnings date? Cutera is scheduled to release their next quarterly earnings announcement on Tuesday, May 14th 2019. View Earnings Estimates for Cutera. What guidance has Cutera issued on next quarter's earnings? Cutera updated its FY 2019 earnings guidance on Wednesday, February, 20th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $165-175 million, compared to the consensus revenue estimate of $172.1 million. What price target have analysts set for CUTR? 4 equities research analysts have issued 12-month target prices for Cutera's stock. Their predictions range from $25.00 to $50.00. On average, they expect Cutera's share price to reach $34.6667 in the next twelve months. This suggests a possible upside of 88.4% from the stock's current price. View Analyst Price Targets for Cutera. What is the consensus analysts' recommendation for Cutera? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cutera. What are Wall Street analysts saying about Cutera stock? Here are some recent quotes from research analysts about Cutera stock: 1. Maxim Group analysts commented, "Market open, CUTR reported lower-than-expected preliminary 4Q18 revenue. The company also announced the resignation of CEO James Reinstein amid Board dissatisfaction with 2018 operational results and stock price performance. CUTR plans to report full 4Q18 results on Market close." (1/8/2019) 2. According to Zacks Investment Research, "Cutera Inc designs, develops, manufactures and markets the CoolGlide family of products for use in laser and other light-based aesthetic applications. The original CoolGlide CV provides permanent hair reduction on all skin types. The second generation CoolGlide Excel incorporated features that added the capability to treat a variety of vascular lesions, which include facial telangiectasia, spider and reticular leg veins. The CoolGlide Vantage added non-ablative skin therapy to the range of applications offered by the system. " (1/4/2019) Has Cutera been receiving favorable news coverage? News articles about CUTR stock have been trending somewhat negative this week, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Cutera earned a media sentiment score of -1.4 on InfoTrie's scale. They also gave news coverage about the medical device company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the immediate future. Who are some of Cutera's key competitors? Some companies that are related to Cutera include Natus Medical (BABY), AxoGen (AXGN), Viewray (VRAY), BioLife Solutions (BLFS), Rockwell Medical (RMTI), Semler Scientific (SMLR), Electrocore (ECOR), Helius Medical Technologies (HSDT), Zynex (ZYXI), Fonar (FONR), BioSig Technologies (BSGM), Stereotaxis (STXS), Second Sight Medical Products (EYES), Edap Tms (EDAP) and IRIDEX (IRIX). What other stocks do shareholders of Cutera own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include Alibaba Group (BABA), Micron Technology (MU), AbbVie (ABBV), NVIDIA (NVDA), Pfizer (PFE), Celgene (CELG), Gilead Sciences (GILD), Paypal (PYPL), Exelixis (EXEL) and Cisco Systems (CSCO). Who are Cutera's key executives? Cutera's management team includes the folowing people: Ms. Sandra A. Gardiner, Exec. VP & CFO (Age 53)Mr. Larry E. Laber, Exec. VP of Sales - North America (Age 48)Mr. Ronald J. Santilli, Exec. Officer (Age 59)Mr. Jason Richey, Interim CEO & Chief Operating OfficerDr. Michael Karavitis, Exec. VP & Chief Technology Officer Who are Cutera's major shareholders? Cutera's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (14.47%), Gamco Investors INC. ET AL (7.11%), Gabelli Funds LLC (4.39%), Dimensional Fund Advisors LP (3.95%), Dimensional Fund Advisors LP (3.95%) and Teton Advisors Inc. (2.83%). Company insiders that own Cutera stock include David A Gollnick, David B Apfelberg, Gregory A Barrett, James A Reinstein, Larry Laber, Miguel Pardos, Ronald J Santilli and Timothy J Oshea. View Institutional Ownership Trends for Cutera. Which major investors are selling Cutera stock? CUTR stock was sold by a variety of institutional investors in the last quarter, including TD Asset Management Inc., Bank of Montreal Can, SG Americas Securities LLC, GSA Capital Partners LLP, MERIAN GLOBAL INVESTORS UK Ltd, Oppenheimer & Co. Inc., Advisors Asset Management Inc. and BlackRock Inc.. Company insiders that have sold Cutera company stock in the last year include David A Gollnick and Larry Laber. View Insider Buying and Selling for Cutera. Which major investors are buying Cutera stock? CUTR stock was acquired by a variety of institutional investors in the last quarter, including Gamco Investors INC. ET AL, Quantum Capital Management, Gabelli Funds LLC, Two Sigma Investments LP, Ontario Teachers Pension Plan Board, Millennium Management LLC, Walthausen & Co. LLC and Assenagon Asset Management S.A.. Company insiders that have bought Cutera stock in the last two years include Gregory A Barrett and James A Reinstein. View Insider Buying and Selling for Cutera. How do I buy shares of Cutera? Shares of CUTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Cutera's stock price today? One share of CUTR stock can currently be purchased for approximately $18.40. How big of a company is Cutera? Cutera has a market capitalization of $255.83 million and generates $162.72 million in revenue each year. The medical device company earns $-30,770,000.00 in net income (profit) each year or ($2.23) on an earnings per share basis. What is Cutera's official website? The official website for Cutera is http://www.cutera.com. How can I contact Cutera? Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The medical device company can be reached via phone at 415-657-5500 or via email at [email protected] MarketBeat Community Rating for Cutera (NASDAQ CUTR)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 241 (Vote Outperform)Underperform Votes: 223 (Vote Underperform)Total Votes: 464MarketBeat's community ratings are surveys of what our community members think about Cutera and other stocks. Vote "Outperform" if you believe CUTR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CUTR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/21/2019 by MarketBeat.com StaffFeatured Article: How does inflation affect different investments?